Myriad Genetics, Inc. is a leading personalized medicine company dedicated to being a trusted advisor and transforming patient lives worldwide with molecular diagnostics. Myriad discovers and commercializes diagnostic tests that: determine the risk of developing disease, accurately diagnose disease, assess the risk of disease progression, and guide treatment decisions across six major medical specialties where molecular diagnostics can significantly improve patient care and lower healthcare costs. For more information on how Myriad is making a difference, please visit the Company's website: www.myriad.com.
Brands: Genesight, Prolaris, Prequel, myChoice CDx, BRACAnalysis CDx, riskScore, myRisk Hereditary Cancer, Foresight, EndoPredict